Research Peptide Comparison
CJC-1295 without DAC 5mg and Ipamorelin 10mg are both Research Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
CJC-1295 without DAC, also referenced in the literature as Modified GRF 1-29, is a 30-amino-acid growth hormone-releasing hormone (GHRH) analog stabilised against enzymatic degradation but without the albumin-binding DAC moiety. Its short half-life produces a pulsatile GH-release profile that more closely approximates endogenous somatotropic signalling, making it a frequent reference compound in GHRH receptor and pituitary-response studies.
Compared to Ipamorelin 10mg, CJC-1295 without DAC 5mg is priced at £27.99 with 99%+ verified purity. Its CAS registry number is 863288-34-0. It has a molecular weight of 3367.97 g/mol.
CJC-1295 without DAC 5mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. At £2.00 less than Ipamorelin 10mg, it is the more affordable option in this comparison.
Ipamorelin is a synthetic pentapeptide GHRP that binds the growth hormone secretagogue receptor (GHS-R1a) with high selectivity, eliciting GH release without meaningful displacement of cortisol, prolactin or aldosterone in published models. Its clean receptor profile has positioned it as a reference compound in somatotropic axis and ghrelin-pathway studies.
Compared to CJC-1295 without DAC 5mg, Ipamorelin 10mg is priced at £29.99 with 99%+ verified purity. Its CAS registry number is 170851-70-4. It has a molecular weight of 711.85 g/mol.
Ipamorelin 10mg is available in 5mg, 10mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £2.00 higher than CJC-1295 without DAC 5mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
